Atlas Trials

Niraparib in Combination with Cabozantinib (XL184) in Patients with Advanced Urothelial Cancer (NICARAGUA)

Clinical trial NCT03425201 · COMPLETED

Trial details

NCT number
NCT03425201
Sponsor
Fundacion CRIS de Investigación para Vencer el Cáncer
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Urothelial Cancer
Start date
2019-10-14
Primary completion
2024-07-31
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.